ABSTRACT In asymptomatic patients with severe aortic regurgitation and normal left ventricular function, aortic valve replacement has been recommended to preserve left ventricular function. In such patients, however, the natural history without operation is unknown. We therefore performed serial studies in 77 asymptomatic patients with normal left ventricular ejection fraction at rest as determined by radionuclide angiography and normal left ventricular fractional shortening as determined by echocardiography; 63 patients had 3 + to 4 + aortic regurgitation visualized by aortic root cineangiography, and the other 14 patients had pulse pressures >70 mm Hg. During mean follow-up of 49 months (range 6 to 114) no patient died and 12 patients underwent aortic valve replacement because of the onset of symptoms (11 patients) 
LEFT VENTRICULAR systolic function is an important determinant of long-term prognosis in patients with chronic aortic regurgitation. Numerous studies indicate that symptomatic patients with impaired preoperative left ventricular function are at risk for irreversible myocardial dysfunction and death from congestive heart failure after aortic valve replacement. '-7 Hence, many investigators recommend that asymptomatic or mildly symptomatic patients with left ventricular dysfunction should undergo operation before the development of severe symptoms. 4' 8-13 The fear of has also led to the recommendation that operation be performed in all patients with significant aortic regurgitation, even if left ventricular function is normal.3' 14-16 However, the natural history of asymptomatic patients with aortic regurgitation and normal left ventricular function is unknown.
We therefore performed serial studies in 77 patients with asymptomatic aortic regurgitation and normal left ventricular systolic function to determine the time course of development of either symptoms or left ventricular dysfunction and to identify echocardiographic and radionuclide angiographic variables predictive of these events. We also studied the postoperative survival and functional results when operation is delayed until the onset of symptoms or of left ventricular dysfunction.
Methods
Patient selection. We studied 77 consecutive asymptomatic patients with severe aortic regurgitation between January 1973 and February 1982, who fulfilled both M mode echocardiographic and radionuclide angiographic criteria of normal resting left ventricular systolic function for our laboratory. At entry into the study, all but one of the patients had normal left ventricular fractional shortening (29% to 44%) as determined echocardiographically. In one patient, the fractional shortening was above normal (50%). Twenty-five patients entered the study between January 1973 and August 1976, before radionuclide angiography was available for evaluation of left ventricular function at our institution. After August 1976, these patients underwent radionuclide angiographic evaluations and all had normal left ventricular ejection fraction at rest (. 45%). In two of these patients the initial radionuclide study demonstrating normal resting ejection fraction was performed after the development of symptoms (after asymptomatic follow-up periods of 30 and 49 months); 23 patients remained asymptomatic at the time of the initial radionuclide study. The other 52 patients entered the study between August 1976 and February 1982; radionuclide angiography was performed at the initial evaluation and demonstrated normal resting left ventricular ejection fraction. Data analysis was performed in August 1982, resulting in potential follow-up periods ranging from 6 to 114 months. At entry into the study, the patients ranged in age from 16 to 67 years (mean 37).
Cardiac catheterization was performed in 63 of the 77 patients and confirmed isolated severe aortic regurgitation in 59 patients, with 3 + to 4+ out of a maximum of 4+ valvular regurgitation visualized by aortic root cineangiography. Three patients had associated ventricular septal defects with left-to-right shunt ratios less than 1 .5: 1. One patient had associated mitral regurgitation and subsequently developed symptoms; he was found at operation to have only minimal mitral regurgitation that did not require concomitant mitral valve replacement, and he is now asymptomatic 24 months after isolated aortic valve replacement. Coronary arteriography was not performed in the asymptomatic patients with normal left ventricular function but was performed preoperatively in all patients over 35 years of age who subsequently developed symptoms or left ventricular dysfunction, or in patients under 35 who subsequently developed angina pectoris. One patient had greater than 50% but less than 75% reduction in luminal diameter of the right coronary artery. No other patient had associated coronary artery disease preoperatively. The 14 asymptomatic patients not catheterized had physical findings compatible with severe isolated aortic regurgitation and systemic pulse pressures of 70 mm Hg or greater.
Throughout the course of the study, aortic valve replacement was performed only in patients who developed (1) symptoms of angina, syncope or near syncope, overt evidence of left ventricular failure (paroxysmal nocturnal dyspnea or orthopnea), or dyspnea (if dyspnea was severe enough to interfere greatly with the patient's quality of life) or (2) evidence of left ventricular dysfunction while asymptomatic, with consistent reductions in fractional shortening and ejection fraction below normal. All but one of the patients undergoing operation had preoperative cardiac catheterization; the exception was a 20-year-old woman who developed symptoms and underwent aortic valve replacement at another institution.
Initial echocardiographic and radionuclide angiographic studies were performed while patients were off all cardiac medications, except one patient, whose initial data were obtained while she was taking digoxin and propranolol. On echocardiographic examination, the degree of left ventricular dilatation in this patient was mild (end-diastolic dimension 57 mm, endsystolic dimension 33 mm). This patient has been followed up for only 8 months, and serial data are not yet available. During the course of the study, we recommended that patients receive no cardiac medications except for antiarrhythmic drugs in those patients demonstrating ventricular tachycardia during routine 24 hr electrocardiogram (ECG) monitoring. After initiation of the study, however, five patients were placed on digoxin by their referring physicians and two patients were placed on hydralazine. In these seven patients, follow-up data over 7 to 61 months were obtained before these drugs were instituted; late studies over 19 to 82 months were repeated while the patients were on either digoxin or hydralazine. In patients undergoing operation, both the preoperative and postoperative studies were performed while patients were off cardiac medications.
Echocardiography 18 Gated blood pool cardiac scintigraphy. Radionuclide cineangiography was performed with patients in the supine position at rest and during maximum symptom-limited exercise. 19 From August 1976 to October 1979, studies were performed with 10 to 15 mCi of technetium-99m-labeled human serum albumin.
After July 1978, we used in vivo labeling of red blood cells with 15 to 20 mCi technetium-99m. Imaging was accomplished with a conventional Anger camera equipped with a high-sensitivity, parallel-hole collimator oriented in a modified left anterior oblique position to isolate the left ventricle. The cardiac image sequence spanning the average cardiac cycle was constructed by computer-based ECG gating, and high temporal resolution (10 to 20 msec/frame) left ventricular time-activity curves were generated from the cardiac image sequence after background correction. Left ventricular ejection fraction was computed automatically from the time-activity curve. '9 Exercise studies were performed with a bicycle ergometer and a restraining harness to minimize patient motion under the camera. Exercise loads were increased by 25 W increments every 2 min until the development of angina or limiting fatigue or dyspnea. Heart rate and blood pressure (by cuff sphygmomanometry) were monitored during exercise. Imaging was begun shortly after the onset of exercise, but only that portion of the data series that occurred during maximal exercise, encompassing approximately the last 2 min of exercise, was selected for analysis.
Treadmill exercise testing. In patients undergoing aortic valve replacement, preoperative exercise capacity was evaluated by the NIH treadmill protocol. In the first stage of this protocol, the treadmill is driven at a constant speed of 2.2 mph at an initial inclination of 0%. Every over the course of 36 months, manifested by a decrease in ejection fraction from 61% to 45%, a decrease in fractional shortening from 31% to 25%, and an increase in end-systolic dimension from 51 to 58 mm. Despite symptoms, left ventricular dysfunction, or both, none of the 12 patients undergoing operation manifested poor preoperative exercise tolerance, with each completing the first stage of our treadmill protocol without limiting symptoms. 20 The clinical course of the 77 patients is indicated in figure 1 . Cox model22 (p < .01) but not when patients were TIME (years) placed in discrete subgroups by the Mantel-Haenszel BData expressed as number of patients, with percent of the total number of patients in each subgroup in parentheses.
ed as tentative because of the small sample size and the few end points.
Change in left ventricular function. Changes in left ventricular dimensions and function during the course of the study are shown in figures 7 and 8. Follow-up echocardiographic data were available in 72 patients and follow-up radionuclide angiographic data were available in 67 patients. Left ventricular end-diastolic dimension did not change significantly for the group between initial and late studies, although increases in end-diastolic dimension greater than 5 mm were observed in 11 patients ( figure 7) . The minimum diastolic dimension in patients undergoing operation was 67 mm. Left ventricular end-systolic dimension increased significantly during follow-up for both patients who remained asymptomatic with normal left ventricular function and those who underwent operation. Five of 12 patients whose end-systolic dimension increased greater than 5 mm developed symptoms, left ventricular dysfunction, or both and underwent operation, including five of nine patients in whom this increase resulted in an end-systolic dimension of 48 mm or greater. The minimum preoperative end-systolic dimension was 48 mm. Left ventricular fractional shortening did not change during serial studies in the clinically stable group, although seven patients manifested a decrease greater than 5%. Fractional shortening significantly decreased in the group undergoing operation and decreased greater than 5% in six patients. Preoperative fractional shortening was at the lower limit of normal in three patients and below normal in seven patients (figure 7). Left ventricular ejection fraction determined by radionuclide angiography (figure 8) decreased during serial studies in both patients who remained asymptomatic with normal left ventricular function and patients who underwent operation. Eight of 17 patients manifesting a decrease in ejection fraction greater than 5% during follow-up developed symptoms, left ventricular dysfunction, or both, including eight of 12 patients in whom this change resulted in an ejection fraction of 50% or less. Preoperative ejection fraction was at the lower limit of normal in two patients and below normal in five patients. The magnitude of the change in ejection fraction from rest Our data also demonstrate a significant association in asymptomatic patients with normal resting left ventricular function between subsequent clinical course and indices of left ventricular function, including left ventricular systolic and diastolic dimensions and fractional shortening determined echocardiographically and the ejection fraction response to exercise determined by radionuclide angiography. Thus echocardiography and radionuclide angiography appear to be valuable techniques in the serial follow-up of the asymptomatic patient. I0 13 However, although these noninvasive data identify patients who are more likely to require operation within a few years, they do not necessarily indicate that such patients, once identified, should undergo early operation before symptoms or left ventricular dysfunction develop. If postoperative results are excellent when valve replacement is delayed until either symptoms or left ventricular dysfunction develop, then an early prophylactic operation would not be justified.
In this regard, of the 12 initially asymptomatic patients with normal left ventricular function in our series who underwent valve replacement after the onset of symptoms, left ventricular dysfunction, or both, none died at operation or during the long-term postoperative course. Moreover, left ventricular dilatation was reversed in all patients when they were reevaluated 6 months after operation (figure 9). The reduction in echocardiographic diastolic dimension is important prognostically, since previous studies indicate that patients with persistent left ventricular dilatation after operation, with postoperative diastolic dimensions of 70 mm or greater, are at risk of death from congestive heart failure.' 201, 29, 30 Left ventricular ejection fraction also improved after operation and was within the normal range in all patients (figure 10).
Thus when aortic valve replacement is delayed in asymptomatic patients with normal left ventricular function until symptoms or left ventricular dysfunction develop, postoperative survival is excellent and left ventricular dimensions and function improve after operation. This is compatible with our previous experience with symptomatic patients who exhibited left ventricular dysfunction but preserved exercise tolerance.20 Hence, the current data suggest that prophylactic aortic valve replacement to preserve left ventricular function is not required in asymptomatic patients with severe aortic regurgitation and normal resting left ventricular function.
